- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Blood Transfusion
Volume 2012 (2012), Article ID 407326, 6 pages
Using Basic Ethical Principles to Evaluate Safety Efforts in Transfusion Medicine
Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, P.O. Box 100275, Gainesville, FL 32610-0275, USA
Received 10 October 2011; Accepted 22 November 2011
Academic Editor: Peter J. M. van den Burg
Copyright © 2012 Jay P. Brooks. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Cambridge Dictionaries Online, “Zero-sum game,” October 2011, http://dictionary.cambridge.org/dictionary/business-english/zero-sum-game.
- “Inpatient Reimbursement May Improve for Blood and Blood Components for Transfusion,” Blood Counts; Blood Centers of the Pacific - Update, October 2011, http://www.bloodcenters.org/docs/hu_may_2002.pdf.
- “Blood services: costs, reimbursement and billing. Blood Counts,” ABC Publications, September 2005, http://www.americasblood.org/download/bloodcounts_v4_n1.pdf.
- R. S. Shilts, And the Band Played On, St. Martin’s Press, New York, NY, USA, 1st edition, 1987.
- M. P. Busch, M. J. Young, S. M. Samson, J. W. Mosley, J. W. Ward, and H. A. Perkins, “Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening,” Transfusion, vol. 31, no. 1, pp. 4–11, 1991.
- L. T. Goodnough, M. E. Brecher, M. H. Kanter, and J. P. Aubuchon, “Medical progress: transfusion medicine (Second of two parts)—blood conservation,” New England Journal of Medicine, vol. 340, no. 7, pp. 525–533, 1999.
- J. P. AuBuchon, J. D. Birkmeyer, and M. P. Busch, “Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood,” Transfusion, vol. 37, no. 1, pp. 45–51, 1997.
- D. A. Marshall, S. H. Kleinman, J. B. Wong et al., “Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States,” Vox Sanguinis, vol. 86, no. 1, pp. 28–40, 2004.
- T. A. Ratko, J. P. Cummings, H. A. Oberman et al., “Evidence-based recommendations for the use of WBC-reduced cellular blood components,” Transfusion, vol. 41, no. 10, pp. 1310–1319, 2001.
- J. D. Sweeney, “Universal leukoreduction of cellular blood components in 2001?” American Journal of Clinical Pathology, vol. 115, no. 5, pp. 666–673, 2001.
- L. T. Goodnough, “Universal leukoreduction of cellular blood components in 2001?” American Journal of Clinical Pathology, vol. 115, no. 5, pp. 674–677, 2001.
- E. C. Vamvakas and M. A. Blajchman, “Universal WBC reduction: the case for and against,” Transfusion, vol. 41, no. 5, pp. 691–712, 2001.
- W. H. Dzik, “Leukoreduction of blood components,” Current Opinion in Hematology, vol. 9, no. 6, pp. 521–526, 2002.
- “BPAC recommends universal leukoreduction,” AABB Newsbriefs, vol. 20, article 16, 1998.
- “Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease (CJD) and variant Creutzfeldt-Jakob Disease (vCJD) by blood and blood products,” Guidance for Industry, January 2002, http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm079711.pdf.
- “Questions and answers on FDA Guidance entitled “Revised Preventative Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob (CJD) Disease and Variant Creutzfeldt -Jakob Disease (VCJD) by Blood and Blood Products,” Guidance for Industry, January 2004, http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm074100.htm.
- “Draft compliance policy guidance for FDA staff and industry (not for implementation),” chapter - 2 sub chapter - 230 Sec. 230.150 blood donor incentives, October 2011, http://www.fda.gov/OHRMS/DOCKETS/98fr/001679gd.pdf.
- “Red Cross to hold raffle for Rolling Stones tickets,” 2011, http://www.gazettetimes.com/news/local/article_f06755c8-7366-57ca-8441-06f71f644b60.html.
- “Save the Date – Quincy 12 hours of giving,” 2011, http://www.redcrossblood.org/news/heartofamerica/save-date-quincy-12-hours-giving.
- “Mustang give away announced! Classic 1966 Mustang coupe given away September 18,” 2011, http://beta.catt.com/article.php?story=20040809111741281.
- “Red Cross Kenneth L. Mitchell Detroit Donor Center hosts special community event, offers opportunity to help save lives & win Saturn Ion. U. S. Newswire,” 2011, http://www.highbeam.com/doc/1P2-13201771.html.
- J. P. Brooks, “The rights of blood recipients should supersede any asserted rights of blood donors,” Vox Sanguinis, vol. 87, no. 4, pp. 280–286, 2004.
- P. Tatchell, “Gay blood ban is homophobic,” 1996, http://www.petertatchell.net/lgbt_rights/blood_ban/blood_ban_on_gays_is_homophobic.htm.
- B. Jennelle, “Bleeding for a change. The Harvard Crimson Online,” 2002, http://www.thecrimson.com/article.aspx?ref=255627.
- E. Garza, “Blood shortages lead some to question ban on gay donors. The Daily Texan,” 2001, http://www.highbeam.com/doc/1P1-45896722.html.
- “Students at Oregon university cancel blood drive to protest policy on gays,” Associated Press, 2003, http://www.ap.org.
- “McGill student group bans blood drives over questionnaire,” CBC News, 2006, http://www.cbc.ca/montreal/story/print/qc_20041803.
- B. Publicover, “York University bans blood donor clinic. The Peak,” 1998, http://www.peak.sfu.ca/the-peak/98-3/issue7/blood.html.
- Z. R. Heineman, “BOND members urged to participate in blood drive. The Harvard Crimson Online,” 2001, http://www.thecrimson.com/article.aspx?ref=120959.
- “Blood Products Advisory Committee 67th meeting [monograph on the Internet],” Rockville (MD): U.S. Food and Drug Administration, 2001http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3649t1.rtf.
- K. Soldan and K. Sinka, “Evaluation of the de-selection of men who have had sex with men from blood donation in England,” Vox Sanguinis, vol. 84, no. 4, pp. 265–273, 2003.
- M. Germain, R. S. Remis, and G. Delage, “The risks and benefits of accepting men who have had sex with men as blood donors,” Transfusion, vol. 43, no. 1, pp. 25–33, 2003.
- B. Spencer, J. Rios, and R. Cable, “Marginal recruitment impact of potential alterations to FDA deferral criteria for men who have sex with men ,” Transfusion, vol. 46, no. 5, pp. 869–870, 2006.
- “Statement of the American Association of Blood Banks before the Blood Products Advisory Committee: donor deferral policy regarding men who have had sex with another man even one time since 1977,” September 2000.
- S Kleinman, “Behavior-based blood donors deferrals in the era of nucleic acid testing (NAT). Statement before the Blood Products Advisory Committee,” ABC Statements 2006, http://www.americasblood.org/download/releases/stmnt_060309_deferrals-msm.pdf.
- W. H. Dzik, “Emily Cooley Lecture 2002: transfusion safety in the hospital,” Transfusion, vol. 43, no. 9, pp. 1190–1199, 2003.
- J. P. Brooks, “Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products,” Transfusion, vol. 45, no. 4, pp. 159S–171S, 2005.
- R. Koshy, “Navigating the information technology highway: computer solutions to reduce errors and enhance patient safety,” Transfusion, vol. 45, no. 4, pp. 189S–205S, 2005.
- J. P. AuBuchon and B. Littenberg, “A cost-effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion,” Transfusion, vol. 36, no. 3, pp. 222–226, 1996.
- L. M. Schwartz, S. Woloshin, W. C. Black, and H. G. Welch, “The role of numeracy in understanding the benefit of screening mammography,” Annals of Internal Medicine, vol. 127, no. 11, pp. 966–972, 1997.
- M. V. Williams, R. M. Parker, D. W. Baker et al., “Inadequate functional health literacy among patients at two public hospitals,” Journal of the American Medical Association, vol. 274, no. 21, pp. 1677–1682, 1995.
- J. A. Gazmararian, D. W. Baker, M. V. Williams et al., “Health literacy among medicare enrollees in a managed care organization,” Journal of the American Medical Association, vol. 281, no. 6, pp. 545–551, 1999.
- L. Katz, “Syphilis testing - statement of the American Association of Blood Banks before the Blood Products Advisory Committee,” 2000, http://www.aabb.org/pressroom/statements/Pages/bpacsyph091400.aspx.
- C. Goodman, S. Chan, P. Collins, R. Haught, and Y. J. Chen, “Ensuring blood safety and availability in the US: Technological advances, costs, and challenges to payment—final report,” Transfusion, vol. 43, no. 8, pp. 3S–46S, 2003.
- FDA, “Use of nucleic acid tests on pooled and individual samples from donations of whole blood and blood components (including source plasma and source leukocytes) to adequately and appropriately reduce the risk of transmission of HIV-1 and HCV – Guidance for Industry,” 2004, http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm080291.pdf.
- C. Bianco, “Actions to promote global safety and availability throughout the world. ABC Publications,” 2001, http://www.hhs.gov/ash/bloodsafety/advisorycommittee/pastmeetings/transcripts/20010419.html.
- J. Leach Bennett, M. A. Blajchman, G. Delage, M. Fearon, and D. Devine, “Proceedings of a consensus conference: risk-based decision making for blood safety,” Transfusion Medicine Reviews, vol. 25, no. 4, pp. 267–292, 2011.